Dhlpp

Verify with FDA CVM →

47 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
47
Total Reports
9
Deaths Reported
1910.0%
Death Rate

Active Ingredients

Dhlpp

Administration Routes

SubcutaneousUnknown

Species Affected

Dog 47

Most Affected Breeds

Chihuahua 5
Retriever - Golden 5
Dachshund (unspecified) 3
Shepherd Dog - German 3
Maltese 3
Shih Tzu 3
Terrier - Yorkshire 2
Pug 2
Spitz - German Pomeranian 1
Pit Bull 1

Most Reported Reactions

Vomiting 15
Lethargy (see also Central nervous system depression in Neurological) 9
Anaphylaxis 8
Lethargy (see also Central nervous system depression in 'Neurological') 7
Pale mucous membrane 7
Not eating 7
Death by euthanasia 5
Ataxia 4
Emesis (multiple) 4
Hypercalcaemia 4
Hyperphosphataemia 4
Leucocytosis NOS 4

Outcome Breakdown

Recovered/Normal
24 (51.1%)
Ongoing
13 (27.7%)
Euthanized
5 (10.6%)
Died
4 (8.5%)
Outcome Unknown
1 (2.1%)

Data Summary

Metric Value
Total adverse event reports 47
Reports involving death 9
Case-fatality rate (reported events) 1910.0%
Distinct species in reports 1
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Dhlpp Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 47 adverse event reports referencing Dhlpp, including 9 reports in which the animal died — a 1910.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Dhlpp. Reported administration routes include Subcutaneous, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Dhlpp reports are Dog (47 reports), with Dog accounting for the largest share. Within those species, Chihuahua (5), Retriever - Golden (5), Dachshund (unspecified) (3) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Dhlpp are Vomiting (15), Lethargy (see also Central nervous system depression in Neurological) (9), Anaphylaxis (8), Lethargy (see also Central nervous system depression in 'Neurological') (7). Of the 47 reports with a coded outcome, Recovered/Normal is the leading category at 51.1%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Dhlpp.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial